Cargando…
The impact of poor medication knowledge on health-related quality of life in people with Parkinson’s disease: a mediation analysis
PURPOSE: This study aimed to determine how limited medication knowledge as one aspect of health literacy contributes to poorer health-related quality of life (HRQoL) in people with Parkinson’s disease (PD). METHODS: Demographical data, PD-specific data (MDS-Unified Parkinson’s Disease-Rating Scale,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023397/ https://www.ncbi.nlm.nih.gov/pubmed/34797508 http://dx.doi.org/10.1007/s11136-021-03024-8 |
_version_ | 1784690339871719424 |
---|---|
author | Zipprich, Hannah M. Mendorf, Sarah Schönenberg, Aline Prell, Tino |
author_facet | Zipprich, Hannah M. Mendorf, Sarah Schönenberg, Aline Prell, Tino |
author_sort | Zipprich, Hannah M. |
collection | PubMed |
description | PURPOSE: This study aimed to determine how limited medication knowledge as one aspect of health literacy contributes to poorer health-related quality of life (HRQoL) in people with Parkinson’s disease (PD). METHODS: Demographical data, PD-specific data (MDS-Unified Parkinson’s Disease-Rating Scale, Nonmotor symptom scale), and data about depressive symptoms (Beck’s depression inventory), cognition (Montreal cognitive assessment), HRQoL (Short-Form Health Questionnaire-36, SF-36), and medication knowledge (names, time of taking, indication, dosage) were assessed in 193 patients with PD. Multivariate analysis of variance (MANOVA), multivariate analysis of covariance, and mediation analyses were used to study the relationship between medication knowledge and HRQoL in combination with different mediators and covariates. RESULTS: Overall, 43.5% patients showed deficits in at least one of the 4 knowledge items, which was associated with higher age, number of medications per day and depression level, and poorer cognitive function, motor function, and lower education level. Using one-way MANOVA, we identified that medication knowledge significantly impacts physical functioning, social functioning, role limitations due to physical problems, and role limitations due to emotional problems. Mediation models using age, education level, and gender as covariates showed that the relationship between knowledge and SF-36 domains was fully mediated by Beck’s Depression Inventory but not by Montreal Cognitive Assessment. CONCLUSIONS: Patients who expressed unawareness of their medication did not necessarily have cognitive deficits; however, depressive symptoms may instead be present. This concomitant depressive symptomatology is crucial in explaining the contribution of nonadherence and decreased medication knowledge to poor quality of life. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-021-03024-8. |
format | Online Article Text |
id | pubmed-9023397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-90233972022-05-06 The impact of poor medication knowledge on health-related quality of life in people with Parkinson’s disease: a mediation analysis Zipprich, Hannah M. Mendorf, Sarah Schönenberg, Aline Prell, Tino Qual Life Res Article PURPOSE: This study aimed to determine how limited medication knowledge as one aspect of health literacy contributes to poorer health-related quality of life (HRQoL) in people with Parkinson’s disease (PD). METHODS: Demographical data, PD-specific data (MDS-Unified Parkinson’s Disease-Rating Scale, Nonmotor symptom scale), and data about depressive symptoms (Beck’s depression inventory), cognition (Montreal cognitive assessment), HRQoL (Short-Form Health Questionnaire-36, SF-36), and medication knowledge (names, time of taking, indication, dosage) were assessed in 193 patients with PD. Multivariate analysis of variance (MANOVA), multivariate analysis of covariance, and mediation analyses were used to study the relationship between medication knowledge and HRQoL in combination with different mediators and covariates. RESULTS: Overall, 43.5% patients showed deficits in at least one of the 4 knowledge items, which was associated with higher age, number of medications per day and depression level, and poorer cognitive function, motor function, and lower education level. Using one-way MANOVA, we identified that medication knowledge significantly impacts physical functioning, social functioning, role limitations due to physical problems, and role limitations due to emotional problems. Mediation models using age, education level, and gender as covariates showed that the relationship between knowledge and SF-36 domains was fully mediated by Beck’s Depression Inventory but not by Montreal Cognitive Assessment. CONCLUSIONS: Patients who expressed unawareness of their medication did not necessarily have cognitive deficits; however, depressive symptoms may instead be present. This concomitant depressive symptomatology is crucial in explaining the contribution of nonadherence and decreased medication knowledge to poor quality of life. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-021-03024-8. Springer International Publishing 2021-11-19 2022 /pmc/articles/PMC9023397/ /pubmed/34797508 http://dx.doi.org/10.1007/s11136-021-03024-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Zipprich, Hannah M. Mendorf, Sarah Schönenberg, Aline Prell, Tino The impact of poor medication knowledge on health-related quality of life in people with Parkinson’s disease: a mediation analysis |
title | The impact of poor medication knowledge on health-related quality of life in people with Parkinson’s disease: a mediation analysis |
title_full | The impact of poor medication knowledge on health-related quality of life in people with Parkinson’s disease: a mediation analysis |
title_fullStr | The impact of poor medication knowledge on health-related quality of life in people with Parkinson’s disease: a mediation analysis |
title_full_unstemmed | The impact of poor medication knowledge on health-related quality of life in people with Parkinson’s disease: a mediation analysis |
title_short | The impact of poor medication knowledge on health-related quality of life in people with Parkinson’s disease: a mediation analysis |
title_sort | impact of poor medication knowledge on health-related quality of life in people with parkinson’s disease: a mediation analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023397/ https://www.ncbi.nlm.nih.gov/pubmed/34797508 http://dx.doi.org/10.1007/s11136-021-03024-8 |
work_keys_str_mv | AT zipprichhannahm theimpactofpoormedicationknowledgeonhealthrelatedqualityoflifeinpeoplewithparkinsonsdiseaseamediationanalysis AT mendorfsarah theimpactofpoormedicationknowledgeonhealthrelatedqualityoflifeinpeoplewithparkinsonsdiseaseamediationanalysis AT schonenbergaline theimpactofpoormedicationknowledgeonhealthrelatedqualityoflifeinpeoplewithparkinsonsdiseaseamediationanalysis AT prelltino theimpactofpoormedicationknowledgeonhealthrelatedqualityoflifeinpeoplewithparkinsonsdiseaseamediationanalysis AT zipprichhannahm impactofpoormedicationknowledgeonhealthrelatedqualityoflifeinpeoplewithparkinsonsdiseaseamediationanalysis AT mendorfsarah impactofpoormedicationknowledgeonhealthrelatedqualityoflifeinpeoplewithparkinsonsdiseaseamediationanalysis AT schonenbergaline impactofpoormedicationknowledgeonhealthrelatedqualityoflifeinpeoplewithparkinsonsdiseaseamediationanalysis AT prelltino impactofpoormedicationknowledgeonhealthrelatedqualityoflifeinpeoplewithparkinsonsdiseaseamediationanalysis |